New NUS study provides insights into early breast cancer development in individuals with BRCA2 mutations

A pioneering study led by the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore and the University of Cambridge (UK) has uncovered vital insights into the distinct effects of BRCA2 mutations on breast tissue cells, shedding light on early breast cancer development in people with BRCA2 mutations.